| Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a … J Jensen, M Omar, C Kistorp, C Tuxen, I Gustafsson, L Køber, ... The lancet Diabetes & endocrinology 9 (2), 106-116, 2021 | 107 | 2021 |
| Type 2 diabetes mellitus and impact of heart failure on prognosis compared to other cardiovascular diseases: a nationwide study B Zareini, P Blanche, M D’Souza, M Elmegaard Malik, CH Nørgaard, ... Circulation: Cardiovascular Quality and Outcomes 13 (7), e006260, 2020 | 34 | 2020 |
| Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes–a Danish nationwide observational study AC Falkentoft, J Andersen, ME Malik, C Selmer, PH Gæde, PB Staehr, ... The Lancet Regional Health–Europe 14, 2022 | 25 | 2022 |
| Heart failure following anti-inflammatory medications in patients with type 2 diabetes mellitus A Holt, JE Strange, N Nouhravesh, SK Nielsen, ME Malik, AM Schjerning, ... Journal of the American College of Cardiology 81 (15), 1459-1470, 2023 | 7 | 2023 |
| Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end‐stage renal disease ME Malik, C Madelaire, M D'Souza, P Blanche, SL Kristensen, C Kistorp, ... European Journal of Heart Failure 22 (5), 813-820, 2020 | 7 | 2020 |
| Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021 ME Malik, AC Falkentoft, J Jensen, D Zahir, S Parveen, A Alhakak, ... The Lancet Regional Health–Europe 29, 2023 | 6 | 2023 |
| Establishing post mortem criteria for the metabolic syndrome: an autopsy based cross-sectional study MR Christensen, A Bugge, ME Malik, JL Thomsen, N Lynnerup, J Rungby, ... Diabetology & Metabolic Syndrome 10, 1-8, 2018 | 3 | 2018 |
| Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease M Malik, A Falkentoft, J Jensen, C Andersson, SL Parveen, L Koeber, ... European Heart Journal 43 (Supplement_2), ehac544. 2692, 2022 | 2 | 2022 |
| Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes ME Malik, C Andersson, P Blanche, M D’Souza, C Madelaire, B Zareini, ... Clinical Research in Cardiology 112 (2), 215-226, 2023 | 1 | 2023 |
| Socioeconomic position and initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes–a Danish nationwide observational study AC Falkentoft, J Andersen, ME Malik, C Selmer, PH Gaede, PB Staehr, ... European Heart Journal 42 (Supplement_1), ehab724. 2622, 2021 | 1 | 2021 |
| Risk of heart failure associated with thiazide diuretics compared with calcium channel blockers in patients with type 2 diabetes: a nationwide nested case-control study ME Malik, C Andersson, J Feifel, TA Gerds, B Zareini, M Malmborg, ... European Heart Journal 41 (Supplement_2), ehaa946. 1244, 2020 | 1 | 2020 |
| Initiation of Medical Therapy for Heart Failure Patients According to Kidney Function: A Danish Nationwide Study D Zahir Anjum, JE Strange, E Fosbøl, CH Garred, ME Malik, C Andersson, ... Clinical Epidemiology, 855-866, 2023 | | 2023 |
| AGE-SPECIFIC TEMPORAL TRENDS OF THE MORTALITY RISK IN PATIENTS WITH HEART FAILURE: A 25-YEAR PERSPECTIVE CH Garred, ME Malik, MW Malmborg, D Zahir, C Andersson, GH Gislason, ... Journal of the American College of Cardiology 81 (8_Supplement), 718-718, 2023 | | 2023 |
| DRUG DISCONTINUATION OF HEART FAILURE THERAPIES ACCORDING TO CHRONIC KIDNEY DISEASE STAGES, AGING AND FRAILTY STATUS: A NATIONWIDE REAL-LIFE STUDY D Zahir, L K⊘ ber, E Fosb⊘ l, ME Malik, CH Garred, M Schou Journal of the American College of Cardiology 81 (8_Supplement), 576-576, 2023 | | 2023 |
| INITIATION OF SGLT-2 INHIBITORS AND GLP1 RECEPTOR AGONISTS ACCORDING TO FRAILTY IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE-A DANISH NATIONWIDE COHORT STUDY ME Malik, JE Strange, J Jensen, D Zahir, C Andersson, EL Fosbol, ... Journal of the American College of Cardiology 81 (8_Supplement), 1643-1643, 2023 | | 2023 |
| Adherence and discontinuation of sglt2-inhibitors and glpl-r agonists in patients with type 2 diabetes with and without cardiovascular disease M Malik, A Falkentoft, J Jensen, C Andersson, SL Parveen, L Koeber, ... EUROPEAN HEART JOURNAL 43, 2692-2692, 2022 | | 2022 |
| The burden of cardiovascular outcomes in heart failure patients with new-onset, prevalent, and without type 2 diabetes B Zareini, P Blanche, A Holt, ME Malik, C Selmer, G Gislason, ... Clinical Research in Cardiology 111 (4), 460-468, 2022 | | 2022 |
| 409 Cardiovascular risk profiles and outcomes in patients with type 2 diabetes-Implications for choice of new diabetes therapies ME Malik, CA Andersson, PB Blanche, CMR Rasmussen, BZ Zareini, ... European Heart Journal 40 (Supplement_1), ehz747. 0104, 2019 | | 2019 |
| Cardiovascular risk profiles and outcomes in patients with type 2 diabetes Implications for choice of new diabetes therapies ME Malik, CA Andersson, PB Blanche, CMR Rasmussen, BZ Zareini, ... EUROPEAN HEART JOURNAL 40, 152-152, 2019 | | 2019 |
| Impact of heart failure on prognosis compared to other complications in patients with diabetes mellitus type 2 B Zareini, PB Blanche, MDD Diederichsen, MEM Malik, SLK Kristsensen, ... EUROPEAN HEART JOURNAL 40, 1928-1928, 2019 | | 2019 |
